Regentis Biomaterials Ltd (RGNT) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2017 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Sep 30 2017 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regentis Biomaterials Ltd   (RGNT)


Regentis Biomaterials Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2017 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Regentis Biomaterials Ltd's ROI in the fourth quarter of 2025?
Regentis Biomaterials Ltd recorded a cumulative net loss of $-14 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -273.58%.

Within the Healthcare sector 904 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 5004.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2017)
III. Quarter
Y / Y Investment Change TTM 330.06 % -27.21 % 18.71 % 285.15 % 111.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 5 5 5 -6
Return On Investment (TTM) -273.58 % -0.59 % -2.19 % -3.62 % -
RGNT's Overall Ranking # 5004 # # # #
Seq. Investment Change TTM 142.58 % -1.04 % -5.38 % 89.33 % -58.94 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 0 0 0 0

RGNT Company Profile >> Back to RGNT Roi Comparisons >> See Annual RGNT Return On Investment



Return On Investment RGNT's Ranking
Within: No.
Industry # 201
Sector # 905
Overall # 5004

Return On Investment Statistics
High Average Low
18.85 %
-72.28 %
-287.69 %
(Dec 31 2013)   (Dec 31 2025)







Financial Statements
Regentis Biomaterials Ltd's IV. Quarter Investments $ 6 Millions RGNT's Balance sheet
Regentis Biomaterials Ltd's IV. Quarter Income $ -14 Millions Quarterly RGNT's Income Statement
RGNT's Income by Division See RGNT's Income by Division


RGNT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2010)
2011
Total Investments in Millions 5 1 1 1 1
Y / Y Investment Growth 623.52 % 22.55 % -7.11 % -4.03 % -
Net Income in Millions -14 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -287.69 % -9.98 % 18.85 % -10.3 % 31.39 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RGNT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RGNT's Competitors
Subscribers only: Roi for Regentis Biomaterials Ltd's Suppliers
Subscribers only: Return On Investment for RGNT's Customers

Other Ratios
RGNT's Roa RGNT's Inventory Turnover Ratio RGNT's Growth Rates RGNT's Dividend Statistics
RGNT's Profitability Ratios RGNT's Asset Turnover Ratio RGNT's Dividend Growth
RGNT's Roe RGNT's Valuation Ratios RGNT's Financial Strength Ratios RGNT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T13:05:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.